Study Identifies Factors Associated With Platinum-induced Ototoxicity in Pediatric Cancer Survivors

Treatment with a higher total cumulative dose of cisplatin, young age, and concomitant furosemide administration are associated with an increased risk of ototoxicity in childhood cancer survivors treated with platinum-based therapy, according to a study published in the European Journal of Cancer.

Read more: http://www.oncologynurseadvisor.com/side-effect-management/study-identifies-factors-associated-with-platinum-induced-ototoxicity/article/573305/